Latest filing published 11 Apr 2022 for ProPhase Labs, Inc., €4,219.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Jason Michael Barr: trading record in brief
All filings by Jason Michael Barr on record concern ProPhase Labs, Inc., in the capacity of board member. The record holds 9 filings, for trades running from 29 September 2017 to 10 March 2022.
In open-market terms, that means 5 purchases worth €29k on one side and 1 sale worth €8,549 on the other. The net balance comes to €21k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants. In 2022 alone, the filings show 2 purchases and no sales.
Half of the purchases are above €4,611 and half below.
The record was last updated on 11 April 2022 with an open-market purchase (€4,219) in ProPhase Labs, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jason Michael Barr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 721 shares@ US$6.4849.0% of flowCommon Stock, par value $0.0005SEC:0001493152-22-009627:0Canonical exit: 8 Jun 2022 (T+90)
- 750 shares@ US$6.4851.0% of flowCommon Stock, par value $0.0005SEC:0001493152-22-007040:0Canonical exit: 8 Jun 2022 (T+90)
2 of 2 declarations